Algedrate + magnesium dioxide

Pharmacological group and basic rationale

The drug Almagelum (Algeldrate + magnesium dioxide) belongs to the broad pharmacological group of agents affecting digestive function. In modern gastroenterology, one of the key objectives is to protect the gastric mucosa from the aggressive action of gastric juice, primarily hydrochloric acid (HCl). Various strategies are used to achieve this, including film-forming agents and antacids.

The pharmacological rationale for creating combination drugs such as Almagelum is based on the synergism of two active substances. A similar approach is seen in other combinations designed to reduce ulcerogenicity (for instance, when magnesium hydroxide is added to acetylsalicylic acid for gastric protection). In the case of algeldrate and magnesium, we achieve a dual strike against aggressive factors: chemical neutralization and physical protection.

Mechanism of action of the magnesium component

The magnesium part of the drug is responsible for the rapid relief of acid aggression. The main pharmacological effect of magnesium compounds in the gastric lumen is antacid action. This consists of the direct chemical neutralization of secreted hydrochloric acid (HCl). By reacting with the acid, magnesium reduces the overall acidity of the gastric juice.

A consequence of this process is a sharp decrease in the damaging effect of acid on the gastric mucosa. This is critical for preventing the formation of ulcers and erosions, as well as for creating conditions under which existing mucosal defects can begin to scar. Reducing ulcerogenicity is the primary goal of using magnesium-containing antacids.

Mechanism of action of the aluminum component (Algeldrate)

Algeldrate is aluminum hydroxide. To understand how it works, it is helpful to recall the mechanism of action of classical film-forming agents (e.g., sucralfate, which is the basic aluminum salt of sulfated sucrose).

Aluminum-containing compounds possess a unique ability to physically protect tissues. Upon entering the acidic environment of the stomach and contacting proteins of the damaged mucosa (in areas of erosions or ulcers), aluminum hydroxide forms a dense protective layer (paste). This paste literally "seals" mucosal defects, isolating them from the further corrosive action of hydrochloric acid. Thus, while magnesium reduces the overall aggressiveness of the environment, aluminum builds a mechanical barrier over the most vulnerable areas.

Comparative characteristics and indications

The term ulcerogenicity refers to the ability to cause damage and ulceration of the mucous membrane. Many factors have a high ulcerogenic potential. Indications for use logically stem from the mechanism of action: these are conditions in which it is necessary to promptly neutralize excess HCl and protect the damaged mucosa.

Why do pharmacology and clinical practice so frequently utilize the combination of aluminum and magnesium salts? Test questions frequently feature single-ingredient drugs: calcium carbonate, aluminum hydroxide, magnesium hydroxide, magnesium sulfate, tripotassium dicitrato bismuthate, or magnesium alginate. Using aluminum alone provides an excellent film-forming effect, but acid neutralization proceeds slowly. Using magnesium alone provides rapid HCl neutralization but fails to provide adequate physical protection of defects. Combining algeldrate and magnesium in a single bottle solves both problems simultaneously.

Presentation and prescription writing rules

According to the prescription reference guide, the drug is available as a suspension in bottles of 170–200 ml. The choice of a liquid dosage form is not accidental. Unlike solid tablets, a suspension has the maximum contact surface area with the gastric mucosa. It evenly coats the walls of the organ, which is critical for the full manifestation of both antacid and film-forming effects.

The drug is prescribed orally, 5–10 ml per dose. For medical students, it is important to be able to correctly fill out a prescription form for this formulation. Since the drug is manufactured under a commercial name in a ready-made liquid form, we prescribe it indicating the form, the name in quotation marks, and the total volume of the bottle.

Example of a prescription for Almagelum: ```latin Rp.: Suspensionis "Almagelum" 170 ml D.S. Oral, 5–10 ml. ``` Pharmacological commentary on the prescription: In the signature, we indicate the route of administration (oral) and the single dose. The patient should be explained that the bottle must be shaken before use to ensure an even distribution of the hydroxide particles.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• The difference between absorbable and non-absorbable antacids.
• Film-forming agents: sucralfate and tripotassium dicitrato bismuthate.
• The concept of drug ulcerogenicity (using NSAIDs as an example).
• Mechanisms regulating hydrochloric acid secretion in the stomach.
• Rules for prescribing liquid dosage forms (suspensions and emulsions).

Other topics in the «Drugs and Prescriptions» section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.